Literature DB >> 26699638

Generation of Recombinant Oropouche Viruses Lacking the Nonstructural Protein NSm or NSs.

Natasha L Tilston-Lunel1, Gustavo Olszanski Acrani2, Richard E Randall3, Richard M Elliott4.   

Abstract

UNLABELLED: Oropouche virus (OROV) is a midge-borne human pathogen with a geographic distribution in South America. OROV was first isolated in 1955, and since then, it has been known to cause recurring outbreaks of a dengue-like illness in the Amazonian regions of Brazil. OROV, however, remains one of the most poorly understood emerging viral zoonoses. Here we describe the successful recovery of infectious OROV entirely from cDNA copies of its genome and generation of OROV mutant viruses lacking either the NSm or the NSs coding region. Characterization of the recombinant viruses carried out in vitro demonstrated that the NSs protein of OROV is an interferon (IFN) antagonist as in other NSs-encoding bunyaviruses. Additionally, we demonstrate the importance of the nine C-terminal amino acids of OROV NSs in IFN antagonistic activity. OROV was also found to be sensitive to IFN-α when cells were pretreated; however, the virus was still capable of replicating at doses as high as 10,000 U/ml of IFN-α, in contrast to the family prototype BUNV. We found that OROV lacking the NSm protein displayed characteristics similar to those of the wild-type virus, suggesting that the NSm protein is dispensable for virus replication in the mammalian and mosquito cell lines that were tested. IMPORTANCE: Oropouche virus (OROV) is a public health threat in Central and South America, where it causes periodic outbreaks of dengue-like illness. In Brazil, OROV is the second most frequent cause of arboviral febrile illness after dengue virus, and with the current rates of urban expansion, more cases of this emerging viral zoonosis could occur. To better understand the molecular biology of OROV, we have successfully rescued the virus along with mutants. We have established that the C terminus of the NSs protein is important in interferon antagonism and that the NSm protein is dispensable for virus replication in cell culture. The tools described in this paper are important in terms of understanding this important yet neglected human pathogen.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26699638      PMCID: PMC4810690          DOI: 10.1128/JVI.02849-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.

Authors:  A Bridgen; F Weber; J K Fazakerley; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Characterization and construction of functional cDNA clones of Pariacoto virus, the first Alphanodavirus isolated outside Australasia.

Authors:  K N Johnson; J L Zeddam; L A Ball
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells.

Authors:  Jose Luiz Proenca-Modena; Renata Sesti-Costa; Amelia K Pinto; Justin M Richner; Helen M Lazear; Tiffany Lucas; Jennifer L Hyde; Michael S Diamond
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

4.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs.

Authors:  Hein Streitenfeld; Amanda Boyd; John K Fazakerley; Anne Bridgen; Richard M Elliott; Friedemann Weber
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis.

Authors:  Xiaohong Shi; Alain Kohl; Ping Li; Richard M Elliott
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

7.  CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215.

Authors:  Benjamin G Hale; Axel Knebel; Catherine H Botting; Caroline S Galloway; Bernard L Precious; David Jackson; Richard M Elliott; Richard E Randall
Journal:  Virology       Date:  2008-11-13       Impact factor: 3.616

8.  La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.

Authors:  Gjon Blakqori; Sophie Delhaye; Matthias Habjan; Carol D Blair; Irma Sánchez-Vargas; Ken E Olson; Ghassem Attarzadeh-Yazdi; Rennos Fragkoudis; Alain Kohl; Ulrich Kalinke; Siegfried Weiss; Thomas Michiels; Peter Staeheli; Friedemann Weber
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

9.  Genetic analysis of members of the species Oropouche virus and identification of a novel M segment sequence.

Authors:  Natasha L Tilston-Lunel; Joseph Hughes; Gustavo Olszanski Acrani; Daisy E A da Silva; Raimunda S S Azevedo; Sueli G Rodrigues; Pedro F C Vasconcelos; Marcio R T Nunes; Richard M Elliott
Journal:  J Gen Virol       Date:  2015-03-03       Impact factor: 3.891

10.  In vitro and in vivo studies of the Interferon-alpha action on distinct Orthobunyavirus.

Authors:  Márcia Cristina Livonesi; Ricardo Luiz Moro de Sousa; Soraya Jabur Badra; Luiz Tadeu Moraes Figueiredo
Journal:  Antiviral Res       Date:  2007-02-28       Impact factor: 5.970

View more
  24 in total

1.  Characterization of the Gamboa Virus Serogroup (Orthobunyavirus Genus, Peribunyaviridae Family).

Authors:  Jannifer Oliveira Chiang; William Marciel de Souza; Márcio Roberto Teixeira Nunes; Gustavo Olszanski Acrani; Amélia Paes de Andrade Travassos da Rosa; Nelma Mesquita de Freitas; Sandro Patroca da Silva; Pedro Henrique Dorta da Silva; Alana Watanabe de Sousa; Sueli Guerreiro Rodrigues; Juarez Antônio Simões Quaresma; Bedsy Dutary; Hilda Guzmán; Nikos Vasilakis; Robert B Tesh; Pedro Fernando da Costa Vasconcelos
Journal:  Am J Trop Med Hyg       Date:  2018-02-08       Impact factor: 2.345

2.  In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.

Authors:  Akinyemi Ademola Omoniyi; Samuel Sunday Adebisi; Sunday Abraham Musa; James Oliver Nzalak; Zainab Mahmood Bauchi; Kerkebe William Bako; Oluwasegun Davis Olatomide; Richard Zachariah; Jens Randel Nyengaard
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 3.  Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Authors:  Solène Lerolle; Natalia Freitas; François-Loïc Cosset; Vincent Legros
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 4.  Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected Orthobunyavirus.

Authors:  Jorge Fernando Travassos da Rosa; William Marciel de Souza; Francisco de Paula Pinheiro; Mário Luiz Figueiredo; Jedson Ferreira Cardoso; Gustavo Olszanski Acrani; Márcio Roberto Teixeira Nunes
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

5.  MicroRNA and cellular targets profiling reveal miR-217 and miR-576-3p as proviral factors during Oropouche infection.

Authors:  Victor Emmanuel Viana Geddes; Anibal Silva de Oliveira; Amilcar Tanuri; Eurico Arruda; Marcelo Ribeiro-Alves; Renato Santana Aguiar
Journal:  PLoS Negl Trop Dis       Date:  2018-05-29

6.  Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus.

Authors:  Utpal Kumar Adhikari; Mourad Tayebi; M Mizanur Rahman
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

7.  Bunyamwera orthobunyavirus glycoprotein precursor is processed by cellular signal peptidase and signal peptide peptidase.

Authors:  Xiaohong Shi; Catherine H Botting; Ping Li; Mark Niglas; Benjamin Brennan; Sally L Shirran; Agnieszka M Szemiel; Richard M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-20       Impact factor: 11.205

Review 8.  Oropouche Fever: A Review.

Authors:  Hercules Sakkas; Petros Bozidis; Ashley Franks; Chrissanthy Papadopoulou
Journal:  Viruses       Date:  2018-04-04       Impact factor: 5.048

9.  Development of reverse genetics systems and investigation of host response antagonism and reassortment potential for Cache Valley and Kairi viruses, two emerging orthobunyaviruses of the Americas.

Authors:  James I Dunlop; Agnieszka M Szemiel; Aitor Navarro; Gavin S Wilkie; Lily Tong; Sejal Modha; Daniel Mair; Vattipally B Sreenu; Ana Da Silva Filipe; Ping Li; Yan-Jang S Huang; Benjamin Brennan; Joseph Hughes; Dana L Vanlandingham; Stephen Higgs; Richard M Elliott; Alain Kohl
Journal:  PLoS Negl Trop Dis       Date:  2018-10-29

10.  Detection of Two Highly Diverse Peribunyaviruses in Mosquitoes from Palenque, Mexico.

Authors:  Anne Kopp; Alexandra Hübner; Florian Zirkel; Daniel Hobelsberger; Alejandro Estrada; Ingo Jordan; Thomas R Gillespie; Christian Drosten; Sandra Junglen
Journal:  Viruses       Date:  2019-09-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.